Background. Socio-economic, geographical, logistic and other features of the Russian pharmaceutical market determine a number of requirements for its wholesale segment. The growth of competition, product saturation and information availability for consumers of the necessary information about the characteristics of goods, their advantages and disadvantages directs the activities of pharmaceutical distributors to search for reserves to increase their competitiveness. One of these areas is the optimization of product line management. Objective. The purpose of the study was to develop a model for managing the assortment policy at the level of a large pharmaceutical distributor, based on the results of analyzing the influence of internal and external factors in the Russian pharmaceutical market and the dynamics of the structure of the product line. Methods. The work used the methods of bibliographic description, content analysis, documentary observation, data copying, SWOT analysis and ABC analysis, the method of expert assessments, modeling. Findings. The SWOT analysis of the operating conditions of a large Russian pharmaceutical distributor revealed a number of external and internal factors affecting economic results.
The article presents a methodological approach to drug provision of patients with various nosologies, receiving pharmacotherapy consecutively on an outpatient and inpatient basis of a medical organization. This approach may be of interest in optimizing prescribing, ensuring the continuity and effectiveness of pharmacotherapy for patients in outpatient, inpatient and post-inpatient treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.